Bibliografía en otros tipos de cáncer

Diversos estudios han mostrado actividad en diversos tumores, como en el hepatoma1-2, en cáncer de vejiga3-4 y, sobre todo en neoplasias hematológicas como leucemia, mieloma y linfoma5-7, tanto in Vitro como in vivo e incluso en seres humanos8.

1- Lin SB, Li CH, Lee S et als. Triterpene- enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 2003; 72:2381-90
2- Weng CJ, Chau CF, Hsie YS et als. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway an reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 2008; 29:147-56
3- Lu QY, Jin YS, Zhang Z et als. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett. 2004; 216:9-20
4- Yuen JW, Gohel MD and Au DW. Telomerase-associated apoptotic events by mushroom ganoderma lucidum on premalignant huan urothelial cells. Nutr Cancer 2008; 60:109-19
5- Muller CI, Kumagai T, O’Kelly J et als. Ganoderma lucidum causes apoptosis in leukaemia, linfoma and multiple myeloma cells. Leuk Res 2006; 30:767-8
6- Cheng KC, Huang HC, Chen JH et als. Ganoderma lucidum polysaccharides in human leukaemia cells: from gene expression to network construction. BMC Genomics 2007; 9:411